Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

Clinicaltrials.gov ID: NCT07184957
db-list-check Status RECRUITING
b-loader Phase
b-people Age 40 - 85 Years
b-bullseye-arrow Enrollments 1000

Conditions

Prostate Cancer

Summary

This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.

Locations

1 location Found with status Recruiting

Status

  • RECRUITING

Central Contacts

Principal Investigator

  • James Wysock, MD

Eligibility Criteria

Inclusion Criteria:

* Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy
* Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.

Exclusion Criteria:

* Men that are not diagnosed with prostate cancer.
* Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.

Study Plan

Men with Prostate Cancer

Men who receive cryotherapy for ablation of clinically localized prostate cancer.

Outcome Measures

Primary Outcome Measures

Treatment Complications

Time Frame: Up to Year 15

PSA-Progression Free Survival

Time Frame: Up to Year 15

Timeline

  • Last Updated
    September 22, 2025
  • Start Date
    September 22, 2025
  • Today
    March 14, 2026
  • Completion Date ( Estimated )
    December 31, 2040

Similar Trials

light-list-check RECRUITING light-blue-people 18 - 80 Years
light-list-check RECRUITING light-blue-people 40 - 90 Years
light-list-check RECRUITING light-blue-people ≥ 18 Years